BetterLife Pharma BETRF
OTC BETRF
$0.26 +0.03 (+13.04%)
At close: Aug 19, 2026 · 4:00 PM EDT

BetterLife Pharma (BETRF) Acquisitions (2018 - 2020)

BetterLife Pharma (BETRF) posted quarterly Acquisitions of $18775.9 for Q4 2020, down 94.25% quarter-over-quarter from $326666.0 in Q4 2018.

BetterLife Pharma (BETRF) Acquisitions (2018 - 2020) Analysis & Trends

BetterLife Pharma's Acquisitions history runs 2 years deep, the most recent figure standing at $18775.9 for Q4 2020.

  • In Q4 2020, Acquisitions changed N/A year-over-year to $18775.9; the TTM figure through Jan 2021 stood at $345441.9 (changed N/A YoY), while the FY2021 annual figure was $18751.0, changed N/A from the prior year.
  • Acquisitions for Q4 2020 stood at $18775.9, down from $326666.0 in the prior quarter.
  • The five-year high for Acquisitions was $333333.0 in Q2 2018, with the low at $18775.9 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn -
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn -
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -
10 BetterLife Pharma 40.15 Mn 42.53 Mn - -

Historic Data

Download Data
DateValue
Oct 31, 2020 18,775.88
Oct 31, 2018 326,666.00
Apr 30, 2018 333,333.00